LSD: Effects, History and Science of Acid

Psychedelics Guide › LSD and Ergot: History, Effects, and Pharmacology

LSD (lysergic acid diethylamide) is a semisynthetic psychedelic derived from lysergic acid, a fundamental chemical precursor found among the alkaloids of ergot (Claviceps purpurea), a fungus that parasitizes cereal grains. That shared chemical root defines this cluster: sharing the same ergoline scaffold, it encompasses both laboratory-synthesized molecules and traditional botanical preparations containing related alkaloids, such as Mexican ololiuqui.

The history of LSD is intimately linked to Swiss chemist Albert Hofmann, who synthesized the compound at Sandoz Laboratories in 1938 and serendipitously discovered its psychoactive properties in 1943—an event celebrated in psychedelic culture as Bicycle Day. Centuries earlier, ergot had already left an indelible mark on European history through a much darker chapter: devastating outbreaks of ergotism, or “St. Anthony’s Fire,” caused by consuming contaminated rye flour, leading to gangrene, severe convulsions, and hallucinations.

This guide brings together Psiconáutica’s articles on LSD and ergot derivatives with an educational and harm reduction focus, designed for readers who want to make informed choices based on objective information. Here you will find history, pharmacology, and current developments in clinical research experiencing a modern revival, alongside key principles for understanding the journey: effects are powerful and unpredictable, heavily contingent on dose, individual physiology, and context (“set and setting”), while illicit market purity is never guaranteed. In contrast to sensationalist myths and rumors surrounding acid, we champion critical examination and personal discernment.

Featured reading

Recent studies and clinical evidence

What the latest clinical research (Nature, JAMA, NEJM, Lancet, PubMed) reveals, reported with scientific rigor and zero hype.

LSD and Generalized Anxiety: What the Phase 2b Trial Showed

What LSD is: lysergic acid, effects, and pharmacology

What LSD is chemically, its structural relationship to lysergic acid, and what pharmacology tells us about its effects, potency, and safety profile.

Rye ergot: from St. Anthony’s Fire to LSD

Rye ergot (Claviceps purpurea) traversed centuries as poison, medicine, and visionary agent—from St. Anthony’s Fire to the shared chemistry connecting ololiuqui and LSD.

Albert Hofmann and the discovery of LSD

Life, laboratory work, and enduring legacy of Albert Hofmann: the birth of LSD-25, the first trip on “Bicycle Day,” and why its creator dubbed it “my problem child.”

LSD in culture, music, and literature

LSD left an indelible impression on twentieth-century literature, music, and thought. These essays explore that cultural footprint with a critical eye.

LSD in psychotherapy and clinical research

From 1950s psychotherapy to modern clinical trials evaluating anxiety, depression, and end-of-life palliative care. These are strictly experimental and regulated protocols, not approved treatments or self-guided therapy.

Harm reduction, adulteration, and LSD myths

Harm reduction strategies for an illicit and frequently misrepresented substance: differentiating genuine LSD from hazardous NBOMe counterfeits and debunking urban legends about acid.

Lysergic acid chemistry and derivatives (historical archive)

Historical documentation and chemical literature regarding lysergamides and related congeners, preserved for archival interest. Reference-only technical material without instructional intent.

Additional articles on this topic

Further reading from Psiconáutica related to this subject.

My Problem Child

Frequently asked questions

What is LSD and where does it come from?

LSD, or lysergic acid diethylamide, is a semisynthetic psychedelic compound. It is produced from lysergic acid, an alkaloid core found in rye ergot (Claviceps purpurea). It was first synthesized by chemist Albert Hofmann at Sandoz Laboratories in 1938, with its psychoactive properties identified in 1943. In most jurisdictions worldwide, it remains a strictly scheduled substance, outside approved clinical trials.

What is the relationship between rye ergot and LSD?

Ergot is a parasitic fungus infecting rye and related grains, generating alkaloids sharing an ergoline ring. Lysergic acid, the chemical backbone of LSD, belongs to this molecular family; thus LSD is regarded as an ergot derivative, although it is not directly extracted in consumable form. Historically, accidental human ingestion of ergot-tainted flour caused ergotism, commonly known as “St. Anthony’s Fire.”

How long do LSD effects last?

According to clinical and educational literature, effects typically manifest within 30 to 60 minutes of ingestion and persist for several hours, with total journey duration generally spanning 8 to 12 hours. Subjective intensity depends heavily on dose, individual mindset, and physical setting (“set and setting”), ranging from euphoric insight to challenging distress. Because black-market dosages vary wildly, effects can differ markedly between experiences.

Is LSD used as a medical treatment?

LSD was intensively explored in psychiatric research throughout the 1950s and 1960s until political shifts shuttered investigation. In recent years, scientific inquiry has seen a resurgence, with trials examining anxiety, major depression, and existential distress in terminal illness. These developments remain experimental, taking place within controlled clinical protocols featuring rigorous psychiatric monitoring. The therapeutic setting, thorough preparation, and guided integration represent indispensable pillars of these studies.

What is an LSD “flashback”?

The term “flashback” refers to the transient recurrence of sensory or perceptual phenomena reminiscent of the acute psychedelic state long after the substance has cleared the body; when chronic, it is classified clinically as Hallucinogen Persisting Perception Disorder (HPPD). It is a recognized though relatively uncommon occurrence whose pharmacological etiology remains subject to ongoing debate, as explored in discussions of Alexander Shulgin’s commentary.

How are risks reduced, and what adulteration hazards exist?

Harm reduction is rooted in respecting individual autonomy by offering clear, objective guidance. No drug experience is entirely without risk, particularly for those with personal or family histories of psychiatric conditions. A paramount safety concern is adulteration: hazardous synthetic compounds, notably 25I-NBOMe and other NBOMes, are periodically sold as “acid.” Submitting samples to drug checking services, avoiding polydrug use, starting with conservative doses, and curating a calm, secure setting are vital harm reduction measures.

LSD and Ergot: History, Effects, and Pharmacology